← Every applicant
Xiamen LP Pharm Co FDA Approvals
5 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| ICOSAPENT ETHYLNew drugAug 6, 2025CAPSULE, ORAL |
| MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDENew drugJul 15, 2025CAPSULE, EXTENDED RELEASE, ORAL |
| TOPIRAMATENew drugNov 5, 2024CAPSULE, EXTENDED RELEASE, ORAL |
| OPIPZANew drugJul 22, 2024FILM, ORAL |
| PRAMIPEXOLE DIHYDROCHLORIDENew drugJun 11, 2021TABLET, EXTENDED RELEASE, ORAL |